Vir Biotechnology Inc (NAS:VIR)
$ 11.23 -0.75 (-6.26%) Market Cap: 1.53 Bil Enterprise Value: 499.26 Mil PE Ratio: 0 PB Ratio: 0.99 GF Score: 55/100

Vir Biotechnology Inc at Morgan Stanley Global Healthcare Conference Transcript

Sep 13, 2022 / 08:05PM GMT
Release Date Price: $20.57 (-7.22%)
Andrew Galler
Morgan Stanley - Analyst

Good afternoon, everyone. I'm Andrew Galler, one of the biotech analysts here at Morgan Stanley. And I'm pleased to be joined by Phil Pang from Vir Biotechnology. Phil is the CMO and Interim Head of Research currently. And before we get jump in, I'm going to read some disclosure statements.

For important disclosures, please see the Morgan Stanley research disclosure website at www.morganstanley.com/researchdisclosures. If you have any questions, please reach out to your Morgan Stanley sales representative.

Questions & Answers

Andrew Galler
Morgan Stanley - Analyst

So, I guess that we can start very broadly, right now. Vir now has a healthy balance sheet given the [Zabouti] windfall. So maybe we could discuss capital allocation priorities broadly.

Phil Pang
Vir Biotechnology Inc - Chief Medical Officer

Thank you, Andrew. So, I think that the key here is not just

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot